Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelaic Acid vs Hydroquinone as Adjuvant to Tranexamic Acid in Melasma
NCT05887219Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Nov 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azelaic acid 15% gel vehicle and hydroquinone in melasma (2 arms), sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Melasma Area and Severity Index at 6 months. Started Nov 2022; status: completed.
02
Drugs
azelaic acid 15% gel vehiclehydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on NCT05887219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05887219.